Vildagliptin is an antidiabetic medicine used alone or in combination with other medicines to treat type 2 diabetes in adult patients.

Vildagliptin is an antidiabetic medication. It works by increasing the release of insulin from the pancreas and decreasing the hormones that raise blood sugar levels. This reduces the fasting and postmeal sugar levels

Major & minor side effects for Vildagliptin

• Headache
• Dizziness
• Weakness
• Constipation
• Sore throat
• Excessive sweating
• Heartburn
• Swelling of face, lips, eyelids, tongue, hands and feet 

Patients are advised to follow a strict diet and exercise regimen along with this medicine for the best possible effect. This medicine is not recommended for use in patients with type 1 diabetes and diabetic ketoacidosis.

This medicine is not recommended for use in pregnant and breastfeeding women unless absolutely necessary.

This medicine should be used with caution in patients who are using insulin secretagogues due to the increased risk of hypoglycemia.

This medicine should be used with caution due to the increased risk of bullous pemphigoid, a hypersensitivity reaction of the skin.

This medicine should be used with caution in patients with a known history of severe arthralgia due to the increased risk of worsening of the patient's condition.

This medicine is not recommended for use in patients below 18 years of age since the safety and efficacy of use are not clinically established.